250+ investors that invest in your industry and stage
Community
Artificial intelligence
Hardware
Marketplace
Consumer
FinTech
Energy
Gaming
Impact
Climate
Proptech
Google
Biotech
EdTech
Health Care
Sustainability
Clean Energy
Venture Capital
Art
Web3
Wellness
Android
Organic Food
Digital Media
Manufacturing
Big Data
Construction
Video Games
Sports
Franchise
eSports
Publishing
Mobile
Enterprise Software
Music
Email
B2B
Social Media
Social Network
Food and Beverage
Medical
Payments
Legal
Real Estate
Local
Internet
Finance
Biotechnology
Travel
Education
Fitness
Recruiting
Hospitality
Mobile Advertising
Platforms
Cannabis
Financial Services
Automotive
Social
Wine And Spirits
Medical Device
Crowdfunding
Retail
CleanTech
Infrastructure
Mobile Apps
Transportation
InsurTech
Enterprise
Beauty
Photography
LGBT
Oil and Gas
Fashion
Film
Life Science
Theatre
SaaS
Non Profit
Renewable Energy
Sporting Goods
Software
Restaurants
Social Impact
Celebrity
Cryptocurrency
Machine Learning
Agriculture (agtech)
Media (entertainment)
Blockchain
Facebook
New Zealand
Ireland
Canada
United States
India
Germany
United Kingdom
South Korea
Australia
Middle East
Indonesia
South Africa
Sri Lanka
Vietnam
Ghana
Egypt
Belarus
Hungary
Europe
Finland
France
Croatia
Gibraltar
Barbados
Georgia
Greece
Qatar
Czech Republic
Faroe Islands
Costa Rica
Japan
Hong Kong
Bahrain
Belgium
Denmark
Bermuda
Estonia
Algeria
Ecuador
Bulgaria
Singapore
Belize
Chile
Ethiopia
Liechtenstein
Panama
Myanmar
Lithuania
Malaysia
Peru
Liberia
Jersey
Lebanon
Norway
Mexico
Italy
Mali
Philippines
Israel
Kuwait
Mauritius
Malta
Morocco
Nicaragua
Togo
Rwanda
Slovenia
Poland
Uganda
San Marino
Sweden
Serbia
Sierra Leone
Thailand
Tanzania
Uzbekistan
Zambia
Turkey
Uruguay
Tajikistan
Russian Federation
Portugal
El Salvador
Puerto Rico
Senegal
Zimbabwe
Tunisia
Venezuela
Ukraine
Taiwan
Dominican Republic
Spain
Bahamas
Iraq
Iceland
Azerbaijan
Nigeria
Namibia
United Arab Emirates
Jamaica
Honduras
China
Isle of Man
Bolivia
Luxembourg
Pakistan
Albania
Armenia
Romania
Jordan
Grenada
Argentina
Bangladesh
Saudi Arabia
Oceania
Africa
LATAM
Asia
Brazil
Kazakhstan
Kenya
Cayman Islands
Cambodia
Cyprus
Oman
Latvia
Marshall Islands
Cameroon
Austria
Switzerland
Colombia
Guatemala
Seychelles
Angel investors
VC Funds
All investors
Download Find emails Save list

Top 50 Medical Startup Investors in Belgium in January 2026

A list of 50 angel investors and VC (Venture Capital) funds that invest in Medical startups based in Belgium. We rank investors based on the number of investments they made in Medical companies from Belgium. We update this investor list every month.

Top 50 Medical Startup Investors in Belgium in January 2026

Investor Medical Belgium investments
Meusinvest (Noshaq) 8
Limburgse Reconversie Maatschappij 5
Capricorn Partners 5
Newton Biocapital 5
Qbic Fund 4
V-Bio Ventures 4
GoBeyond 3
S.R.I.W. 3
Mérieux Equity Partners 3
Annie Vereecken 3
Mérieux Equity Partners 3
PMV 3
Gemma Frisius Fund 3
Fund+ 3
WING by Digital Wallonia 3
White Fund 2
Omnes Capital 2
Sambrinvest 2
Buysse & Partners 2
Volta Ventures 2
BAN Vlaanderen 2
Inventures SA 2
BioGeneration Ventures 2
Forbion Capital Partners 2
Be Angels 2
Spinventure 2
Flanders Future Techfund 2
Thuja Capital 2
NV Industriebank LIOF 1
SFPI-FPIM 1
Investsud 1
Virginie Saverys 1
Annemie Van de Casteele 1
Ackermans & van Haaren 1
Yves Berquin 1
Jurgen De Baerdemaeker 1
Limburg Startup 1
Hunza Ventures 1
Sofinnova Partners 1
Yonjin Venture 1
The CoFoundry 1
Gimv 1
Delta Partners 1
TCD Capital (ex TheClubDeal) 1
Jean Dessain 1
Fountain Healthcare Partners 1
Yves Beudin 1
georges verpraet 1
Allegro Investment Fund 1
Evren Ucok 1

Reach every investor

Get a list of investors who already back your industry, stage, and country. Emails & phones included.

Find investors — It's Free!
Investor list
Meusinvest (Noshaq)
VC Fund · Liège, Liege, Belgium · 1 investment in the past 12 months

Noshaq offers financial services to help businesses develop.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Seed, Funding Round
  • Belgium, France, Germany

Portfolio highlights

  • TrustUp — TrustUp is the home contractors platform, connects homeowners with verified quality home improvement.
  • Veoware — More coverage, shorter revisit time. Increasing target collection frequency through modular next-gen actuator technology.
  • Le Fourgon — Le Fourgon provides contained drinks for home delivery. They offer milk, water, beer, wine, fruit juice, and sodas. They allow customers to have their drinks delivered free of charge during the day.
Show all investments...

Limburgse Reconversie Maatschappij
VC Fund · Hasselt, Limburg, Belgium · 1 investment in the past 12 months

Oxygen for growth - LRM

Show more...

Investment focus

  • Information Technology, Software, Biotechnology
  • Funding Round, Series A, Seed
  • Belgium, United States, The Netherlands

Portfolio highlights

  • Cumul.io — Create powerful dashboards in minutes. Share with your teams, or integrate in your platform. Drive growth in your business today!
  • ADLC — ADLC employs drone technology to deliver logistics services, allowing businesses to implement drone-based solutions without having to manage them in-house. The company is focused on enhancing last-mile delivery in maritime and offshore environments. ADLC now conducts drone delivery services in the Port of Antwerp in collaboration with SGS, atesting and certification company, and works with companies such as BASF. Its drones have reduced delivery times and environmental effect, boosting efficiency sixfold and lowering CO2 emissions by up to 80% for petrochemical sample deliveries.
  • Raw Stadia — Raw Stadia is a sports technology company that specializes in surface player interactions.
Show all investments...

Capricorn Partners
VC Fund · Leuven, Vlaams-Brabant, Belgium

Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds

Show more...

Investment focus

  • Biotechnology, Health Care, Software
  • Funding Round, Series B, Series A
  • Belgium, United States, The Netherlands

Portfolio highlights

  • InsectSense — MIMICKING HOW INSECTS SENSE | Biomimetic technology based on the sensing mechanism of insects. A deeptech platform that applies synthetic biology, microfluidics and is powered by machine learning.
  • Minze Health — Digital Urology Starts Here from symptom to solution Home-based digital diagnostics and therapeutics for Male LUTS/BPH and OAB. Shaping the future of urology through meaningful data. Get In Touch Our Mission We're redefining how Male LUTS/BPH and OAB are diagnosed and treated Today's Challenge Lower urinary tract symptoms (LUTS) affect a growing group of patients.
  • fruitcore robotics — fruitcore robotics is a robotic system that leverages intelligent software and innovative mechatronics.
Show all investments...

Newton Biocapital
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Our mission is to mature innovation and support the growth of our portfolio companies to create value for patients, society, local ecosystems, and investors.

Show more...

Investment focus

  • Biotechnology, Medical, Health Care
  • Series A, Funding Round, Seed
  • Belgium, Japan, France

Portfolio highlights

  • AdipoPharma — AdipoPharma SAS is dedicated to learning more about the role of adipocyte cells in diabetes. AdipoPharma is using the adipocyte's power to treat insulin resistance, type 2 diabetes, and other diseases.
  • AbolerIS Pharma — AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
  • Tensegrity Pharma — Tensegrity Pharma is the developer of a novel drug designed to minimize bottlenecks and provide innovative value to patients.
Show all investments...

Qbic Fund
VC Fund · Belgium, Wisconsin, United States · 2 investments in the past 12 months

The Qbic Fund is a multi-sector fund supporting spin-off companies of the Ghent, Brussels and Antwerp university associations and of VITO. Through its strategic partnership with the universities of Ghent, Brussels and Antwerp, and VITO, the Qbic Fund has early and privileged access to promising research projects at these partner universities. Ourinvestment approach is based on early in-depth and independent review and analysis followed by hands on involvement and support.In May 2012 the Qbic Fund held its first close and currently it has over € 30 million under management. The Qbic Fund is backed by several public and private investors and managed by Qbic Venture Partners.

Show more...

Investment focus

  • Biotechnology, Software, Health Care
  • Seed, Funding Round, Series A
  • Belgium

Portfolio highlights

  • Pleevi — AI powered smart charging to charge fleet more cost-efficient and cleaner on professional sites
  • Weavely — Design forms in Figma - publish with Weavely. We turn your visual ideas into interactive, web-based forms.
  • Eyeo — eyeo revolutionizes imaging with color splitter sensors. Capture sharper, brighter images in low light using optical waveguide innovation, discover how it works
Show all investments...

V-Bio Ventures
VC Fund · Gent, Oost-Vlaanderen, Belgium · 1 investment in the past 12 months

V-Bio Ventures is an independent venture capital firm specialized in building and financing young, innovative life science companies. The fund invests throughout Europe in start-up and early-stage companies with high growth potential focusing on technologies that provide transformational improvements in the biotech, pharmaceutical and agriculturalsectors.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Series B, Seed
  • Belgium, France, United Kingdom

Portfolio highlights

  • Avidicure — Avidicure is developing dual agonistic avidity-engineered multifunctional antibodies, AVC-Boosters, as monotherapy for treatment of cancer
  • ATB Therapeutics — ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.
  • Confo Therapeutics — Confo Therapeutics is a clinical-stage company committed to accelerating novel GPCR-directed medicines for metabolic & endocrine diseases.
Show all investments...

GoBeyond
VC Fund · Zürich, Zurich, Switzerland

GoBeyond is a FinTech company transforming angel investing into a new scalable asset class for small and large, novice to experienced investors. It offers a unique deal platform, portfolio tools, syndication/pooling, due diligence, investment monitoring services, training and certified deal leaders.Its clients are individuals, familyoffices, professional groups and corporations. It is active in the EU, Switzerland and the US. GoBeyond also offers educational training modules for angel investors in 11 categories.

Show more...

Investment focus

  • Information Technology, Medical, Software
  • Funding Round, Seed, Series A
  • Switzerland, Germany, United Kingdom

Portfolio highlights

  • Stylect — Stylect is a mobile app to to help women discover their perfect shoe. They aggregate products from multiple websites and based on users' preferences (that they gather through a hot-or-not interface), they recommend better products. Their users are able to keep track of and buy the products they like and receive notifications whenever a productthey love goes on sale. Finally, They use geolocation to let their users know when a shoe is selling in a store nearby.
  • Fastree3D — Fastree3D imaging sensors help recognize and measure distance to fast moving objects in real-time, enabling driving assistance or autonomous navigation. Fastree3D SA is a fabless semiconductor company, spin-off from EPFL Lausanne, Switzerland founded in September 2013 (UID CHE-291.330.490). The company subsidiary Fastree3D B.V. performs researchwith TU-Delft, Netherlands (KvK 58866973).
  • Prestodiag — Prestodiag develops, manufactures and sells innovative solutions for rapid detection of bacteria. Their analytical solutions are based on an innovative optics technology called Surface Plasmon Resonance imaging and allow detection and identification of pathogenic bacteria such as Salmonella, Listeria or E.coli. They provide users with a result injust a few hours instead of 1 to several days. Their market is primarily the food safety sector, and also on medical and environmental applications.
Show all investments...

S.R.I.W.
VC Fund · Liège, Liege, Belgium

The S.R.I.W. Group is an institution at the heart of the financial market that assists entrepreneurs in creating and developing businesses in the Walloon region. It reflects the effort of Wallonian industry in facing the challenges of the creation of economic value in the 21st century. Since its creation in 1979, the Société Régionaled’Investissement de Wallonie has continuously been expanding its abilities to adapt and anticipate as well as its flexibility in order to meet the requirements of its partners who are confronted with the evolution of the world economy. The principles of good governance, a strong business culture and shared values at the heart of the Group constitute important assets to capture the changing realities of the market and progress in a sustainable development perspective.

Show more...

Investment focus

  • Biotechnology, Health Care, Manufacturing
  • Funding Round, Series A, Series B
  • Belgium, United States, Spain

Portfolio highlights

  • Univercells — We are biotech innovators, rooted in Belgium, driven by one purpose: To transform how biotech drugs are made so everyone, everywhere, can get them.
  • Intressa Vascular — Intressa Vascular provides innovative solutions to address life-threatening cardiovascular conditions such as aortic dissection.
  • Santero Therapeutics — This is the homepage of the website
Show all investments...

Mérieux Equity Partners
VC Fund · Lyon, Rhone-Alpes, France · 2 investments in the past 12 months

Mérieux Equity Partners (“MxEP”) is a management company dedicated to venture, growth and LBO investments in the healthcare and nutrition sectors. MxEP actively supports entrepreneurs and industrial companies with differentiated products and services, by providing privileged access to its expertise and international network. MxEP currently managesmore than €600m AUM and has recently launched a new vehicle MP3 of €350m dedicated to growth/LBO.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical Device
  • Series A, Funding Round, Private Equity
  • France, United States, Belgium

Portfolio highlights

  • DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
  • Ceva Santé Animale — Ceva Sante Animale S.A. engages in the research, development, production, and marketing of pharmaceutical products and vaccines for companion and farm animals. They work with welfare and social programmes around the world to bring this vision to life – anywhere their products and know-how can make a difference and with all kinds of partners. FromUganda, working with small-scale livestock owners and vets to stop sleeping sickness in its tracks, to the UK and USA, where they supply the biggest animal welfare charities with Adaptil® collars to help re-home shelter dogs.
  • CorFlow Therapeutics — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
Show all investments...

Annie Vereecken
Angel

Annie Vereecken

Show more...

Investment focus

  • Biotechnology, Medical, Hospital
  • Seed, Series A, Funding Round
  • Belgium

Portfolio highlights

  • Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
  • Sensolus — Sensolus provides care-free tracking of your valuable non-powered assets directly from the cloud.Sensolus offers turnkey solutions for wireless, low-power context-aware sensing. Sensolus developed a personal product line of low-power tracker systems called STICKNTRACK.Sensolus is built upon many years of expertise in low-power networks,wireless sensor design, cloud-based sensor management, analytics, and applications.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Show all investments...

Mérieux Equity Partners
VC Fund · Lyon, Rhone-Alpes, France · 1 investment in the past 12 months

Mérieux Equity Partners (“MxEP”) is a management company dedicated to venture, growth and LBO investments in the healthcare and nutrition sectors. MxEP actively supports entrepreneurs and industrial companies with differentiated products and services, by providing privileged access to its expertise and international network. MxEP currently managesmore than €600m AUM and has recently launched a new vehicle MP3 of €350m dedicated to growth/LBO.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Private Equity, Funding Round
  • France, Belgium, United Kingdom

Portfolio highlights

  • DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
  • Prothea Technologies — Prothea Technologies is a private medical technology business to provide lung cancer biopsy and therapy in a single hospital visit.
  • CorFlow Therapeutics — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
Show all investments...

PMV
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Do and dare company

Show more...

Investment focus

  • Software, Biotechnology, Health Care
  • Series A, Seed, Series B
  • Belgium, United States, The Netherlands

Portfolio highlights

  • IVEX — IVEX offers Repeatable and Scalable Testing & Validation Data Analytics solutions for ADAS/AD Vehicles.
  • LindaCare — LindaCare develops solutions for implantable cardiac device remote monitoring. From intuitive dashboards for caregivers to managed remote monitoring service, LindaCare is at the forefront of the monitoring revolution.
  • Magics Technologies — Magics Technologies is a nuclear research center that develops autonomous machines for sustainable energy sources.
Show all investments...

Gemma Frisius Fund
VC Fund · Leuven, Vlaams-Brabant, Belgium

Gemma Frisius Fund KU Leuven is a seed capital fund that aims to stimulate the creation and growth of university related spin-off companies.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Seed, Series B, Series A
  • Belgium, France, United Kingdom

Portfolio highlights

  • Magics Technologies — Magics Technologies is a nuclear research center that develops autonomous machines for sustainable energy sources.
  • Tavira Therapeutics — Tavira Therapeutics develops an innovative technology that equips AAV vectors with molecules to accurately target the intended tissues.
  • Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
Show all investments...

Fund+
VC Fund · Leuven, Vlaams-Brabant, Belgium · 1 investment in the past 12 months

Fund+ is a venture capital firm that invests in companies operating in the diagnostics, therapeutics, medical devices, and life science sectors. The firm wants to create sustainable shareholders' value, contribute to the development of a leadership position in the life sciences sector, and generate a tangible, beneficial societal impact.Fund+ was established in 2015 and is based in Leuven, Belgium.

Show more...

Investment focus

  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • Belgium, United States, Spain

Portfolio highlights

  • Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
  • Confo Therapeutics — Confo Therapeutics is a clinical-stage company committed to accelerating novel GPCR-directed medicines for metabolic & endocrine diseases.
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
Show all investments...

WING by Digital Wallonia
VC Fund · Liège, Liege, Belgium

W.IN.G by Digital Wallonia invests in SAAS, advanced tech and deep tech startups (AI, drones, medtech, IOT,...). W.IN.G brings smart money by helping startups by bi-weekly interactions and providing an operating teams (seasonal entrepreneurs being hands-on with the portfolio).

Show more...

Investment focus

  • Software, Health Care, Internet
  • Seed, Convertible Note, Series A
  • Belgium

Portfolio highlights

  • IONNYK — IONNYK is a new medium of art photography, containing millions of tiny ink capsules.
  • MYOCENE — Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring muscle fatigue and performance.
  • Soil Capital Belgium — Discover Europe's first certified, multi-national carbon farming programme that rewards regenerative agriculture.
Show all investments...

White Fund
VC Fund

For game changers in medtech

Show more...

Investment focus

  • Health Care, Medical, Biotechnology
  • Seed, Series A, Series B
  • Belgium

Portfolio highlights

  • Axithra — Axithra provides therapeutic medication monitoring and measures beta-lactam antibiotic concentrations in blood.
  • Minze Health — Digital Urology Starts Here from symptom to solution Home-based digital diagnostics and therapeutics for Male LUTS/BPH and OAB. Shaping the future of urology through meaningful data. Get In Touch Our Mission We're redefining how Male LUTS/BPH and OAB are diagnosed and treated Today's Challenge Lower urinary tract symptoms (LUTS) affect a growing group of patients.
  • Clouds of care — Increasing your probability of success through the adoption of meaningful endpoints, starting from electrophysiology.
Show all investments...

Omnes Capital
VC Fund · Paris, Ile-de-France, France

Omnes VC is the Venture Capital arm of Omnes Capital, a leading private equity firm dedicated to energy transition and innovation with €4.8 billion in assets under management and a 20 year + experience in: venture capital, buyout & growth capital, private debt, renewable energy, co-investment, secondary funds of funds. Omnes Capital is fullyindependent.With 65 business sales including 14 IPOs carried out in 16 years, Omnes VC is one of the key players in France in financing innovative SMEs with expertise in both Technology and Healthcare sectors. Omnes VC has supported 120 companies and has invested more than €500M in businesses such as Scality, Novaled, BioVex, arGEN-X, Pixium, Blablacar.

Show more...

Investment focus

  • Biotechnology, Software, Health Care
  • Series A, Funding Round, Series B
  • France, Germany, United States

Portfolio highlights

  • Caracol — Lead the future of manufacturing thanks to Caracol's 3D printing technologies. Discover our solutions for industrial, Large Format Additive Manufacturing.
  • Complix — Complix is a biopharmaceutical company focused on the discovery and development of Alphabodiesâ„¢, a novel class of biopharmaceuticals that offer significant advantages over existing protein based therapies. Alphabodiesâ„¢ bind with high affinity to a wide range of disease targets and are particularly suited to address certain targets that aredifficult to reach with antibodies or other types of protein scaffolds. Due to their unique stability and versatility Alphabodiesâ„¢ can be delivered via alternative non-injectable routes of administration, unlike most therapeutic proteins.
  • Amakem — Amakem is a kinase platform company focusing on ophthalmology and is developing new treatments for serious eye conditions. Amakem's product pipeline is based on its unique ‘Localized Drug Action' platform which is designed to generate safe and effective novel kinase inhibitors that minimize systemic exposure with the aim of reducingside effects.
Show all investments...

Sambrinvest
VC Fund · Gosselies, Hainaut, Belgium

Sambrinvest is an active venture capital player in the region of Charleroi - Thuin.

Show more...

Investment focus

  • Biotechnology, Health Care, Information Technology
  • Seed, Series A, Series B
  • Belgium, France, Spain

Portfolio highlights

  • AdipoPharma — AdipoPharma SAS is dedicated to learning more about the role of adipocyte cells in diabetes. AdipoPharma is using the adipocyte's power to treat insulin resistance, type 2 diabetes, and other diseases.
  • AbolerIS Pharma — AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
  • ATB Therapeutics — ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.
Show all investments...

Buysse & Partners
VC Fund · Antwerpen, Antwerpen, Belgium

Buysse and Partners is a private equity investment group based in Antwerpen that offers smart equity, a growth fund, and partnerships.

Show more...

Investment focus

  • Software, Cloud Computing, FinTech
  • Series A, Seed, Funding Round
  • Belgium, United Kingdom, The Netherlands

Portfolio highlights

  • Twikit — Deliver unforgettable customer experiences with real time 3D product configurators, linked to your existing order and manufacturing flows.
  • Bluebee — Delivering a streamlined way for users to analyze, explore, and manage large-scale genomics data in the cloud.
  • moonbird — Slow breathing is the easiest way to relieve stress and promote relaxation. Moonbird makes it intuitive and easy to do slow breathing exercises.
Show all investments...

Volta Ventures
VC Fund · Gent, Oost-Vlaanderen, Belgium

Volta Ventures is a venture capital firm that offers seed & early stage VC for internet & software companies in the Benelux.The fund’s team, with active support from some 30 business angels, expects to make a substantial impact on every company it invests in by working with the founders and management to identify new markets andcustomers, hire senior talent, provide ongoing guidance and arrange further financing rounds.Volta Ventures has offices in Ghent and Amsterdam.

Show more...

Investment focus

  • Software, Information Technology, Artificial Intelligence
  • Seed, Series A, Funding Round
  • Belgium, The Netherlands, Luxembourg

Portfolio highlights

  • NannyML — Open Source Library for post deployment data science
  • Nodalview — Nodalview helps real estate agents deliver cutting edge content and an impressive buying experience for happy and loyal customers.
  • Predikt — Predikt empowers finance leaders to navigate today’s volatile markets with clarity and confidence. By integrating advanced AI, external market data, and internal financial metrics, Predikt transforms forecasting into a strategic advantage.Our pioneering Confidence Intelligence platform:- Provides transparency and automation to reduceforecasting uncertainty. - Enables CFOs to assess risks, identify opportunities, and align teams globally. - Turns data into decisions that foster resilience and drive growth.We understand the challenges finance leaders face: juggling a high-level view with local market complexities. That’s why Predikt is designed to enhance collaboration, challenge assumptions, and provide confidence in every number.Founded by a Swiss-Belgian team in 2023, Predikt is democratizing predictive technology, equipping finance teams to make smarter decisions and thrive amid uncertainty.
Show all investments...

BAN Vlaanderen
VC Fund · Hasselt, Limburg, Belgium

BAN Vlaanderen is the business angel network in Flanders, a value-added platform within which new or growing businesses are brought into contact with informal private investors, called Business Angels. Looking for venture capital This Business Angels bring not only money but also their own know-how, experience and contacts. Are connecting servicesoffered. Both the entrepreneurs and the business angelsBAN Vlaanderen is no investment, it does not own shares or take any investment decisions, nor for its own account or on behalf of the affiliates. Instead, it is a market where supply and demand are brought together. The information on this site is intended to initiate the purpose and operation of BAN Vlaanderen. For more information you can always contact one of our regional offices.BAN Vlaanderen is an association that aims to stimulate the development, support and promotion of entrepreneurship and investment culture in Belgium. Economic growth in Belgium

Show more...

Investment focus

  • Health Care, Medical, Apps
  • Funding Round, Seed, Series A
  • Belgium

Portfolio highlights

  • OutKept — Can you be phished? Verhoog je bewustzijn en naleving met volledig geautomatiseerde phishing-simulaties gemaakt door een community van ethische phishers.
  • Pom — POM stands for Peace of Mind. And it's exactly that worry-free feeling that they want their customers to achieve through their invoice management solutions, both for the receiver and the sender.Their goal is to eliminate the senseless time and effort spent because of inefficient systems. And thus freeing up time to do the things that reallymatter.
  • Oncomfort — Oncomfort’s solution for digital sedation is a completely new method for relieving patients’ pain and anxiety before, during and after medical procedures. This revolutionising digital therapy combines clinical hypnotherapy and integrative therapeutic techniques through Virtual Reality.
Show all investments...

Inventures SA
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Inventures is a European venture capital fund that builds a better world through a portfolio of investments in sustainable businesses.The firm has two funds: Inventures I & Inventures II.Inventures was created to support early stage smart and innovative European businesses, to support sustainable job growth and empower entrepreneurs.Inventures empowers citizenship co-investments through a crowdfunding platform, MyMicroInvest.

Show more...

Investment focus

  • Health Care, Manufacturing, Biotechnology
  • Series A, Seed, Funding Round
  • Belgium, France, United Kingdom

Portfolio highlights

  • BiOceanOr — BiOceanOr harnessed the power of Marine Biology and AI to deliver bio-guided services that optimize fish welfare and fish growth, while supporting aquaculture sustainability standards
  • myskillcamp — Myskillcamp is a digital learning platform and educational design support service. Myskillcamp supports their customers in the digital transformation of their company and the launch of their Digital Learning project. From the audit of needs to the design of engaging educational devices, through a pilot phase, they make a point of honor to adapt thedigital to the specificities of each and give it meaning.With their online platform, businesses can manage their learner communities and connect all their partners in one place. Their tool also allows businesses to structure training spaces by skills, trades, brands within camps. In parallel, businesses can create educational content from scratch, select a map in their marketplace, or plan sessions in-class. Businesses can organize the distribution of their training to a single learner or to a whole group.
  • Octave — Octave develops Battery Energy Storage Systems (BESS) and Energy Management Systems (EMS) for commercial and industrial companies. Our flexible and scalable energy storage systems, built with high-quality lithium-ion batteries, support organizations in their energy transition. Thanks to our in-house developed Energy Management System, we deliver a highly performant, cost-efficient, and reliable solution that optimizes energy use, increases flexibility, and reduces energy costs.
Show all investments...

BioGeneration Ventures
VC Fund · Naarden, Noord-Holland, The Netherlands · 2 investments in the past 12 months

Shaping new life-science ventures.

Show more...

Investment focus

  • Biotechnology, Therapeutics, Health Care
  • Series A, Funding Round, Seed
  • The Netherlands, United States, Belgium

Portfolio highlights

  • Citryll — Citryll is a private pharmaceutical company that develops pharmaceutical drugs used to treat autoimmune and other human diseases. The company offers formation, function, and clearance of NETs downstream of the protein citrullination pathway catalyzed by Peptidylarginine Deiminase (PAD) enzymes that enable doctors to help in the treatment of lupus,vasculitis, pulmonary fibrosis, rheumatoid arthritis and organ damage due to sepsis.Citryll was established in 2015 and is headquartered in Oss, The Netherlands.
  • Rhygaze — Rhygaze develops a novel gene therapy that targets cone cells to restore vision in patients suffering from diseases causing blindness.
  • Avidicure — Avidicure is developing dual agonistic avidity-engineered multifunctional antibodies, AVC-Boosters, as monotherapy for treatment of cancer
Show all investments...

Forbion Capital Partners
VC Fund · Naarden, Noord-Holland, The Netherlands · 6 investments in the past 12 months

Impacting the future of medicine.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • United States, United Kingdom, The Netherlands

Portfolio highlights

  • Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
  • Eeden — Eeden engages in the manufacture and supply of textiles.
  • Granite Bio — Targeting fundamentals of Inflammation, Autoimmunity and Fibrosis. Granite Bio develops first-in-class therapeutic antibodies depleting pathogenic cells with the potential to transform inflammatory and fibrotic diseases.
Show all investments...

Be Angels
VC Fund · Louvain-la-neuve, Vlaams-Brabant, Belgium

Early stage Entrepreneurs Coaching and FinancingOne of Europe's leading Business Angels Networks. We connect innovative growth companies to equity finance and coaching by experienced angel investors. The network is 250 members strong and has been assisting innovative entrepreneurs to find financing for more than 10 millions Euros in thelast 4 years.

Show more...

Investment focus

  • Software, Information Technology, SaaS
  • Seed, Pre-Seed, Funding Round
  • Belgium, France, Spain

Portfolio highlights

  • Savics — Savics offers digital solutions for health actors to improve their data management, disease diagnostics and GeneXpert connectivity.
  • DeftHedge — DeftHedge is an application addressed to business leaders, and CFOs facing volatility of foreign exchange market.
  • NIUM — NIUM is a startup focused on personalized nutrition and gut microbiome research. NIUM created science-based solutions to transform nutrition research and product development.
Show all investments...

Spinventure
VC Fund · Angleur, Liege, Belgium

Spinventure supports the creation of spin-off companies that aim to industrialize and commercialize the result of scientific research. Spinventure was born from a collaboration between MEUSINVEST and the University of Liège. It is headquartered in Angleur, Belgium.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical
  • Series A, Funding Round
  • Belgium

Portfolio highlights

  • Dim3 — Improve patients outcome - Deliver actionable insights - Save healthcare costs
  • Elysia — Elysia developed solution dedicated to quality control laboratories for the production of Radio Pharmaceuticals.
  • Convert Pharmaceuticals — Convert Pharmaceuticals develops prodrugs that are inert upon administration to patients, but transform into potent anti-cancer agents upon entering tumors.
Show all investments...

Flanders Future Techfund
VC Fund

Flanders Future Techfund operates as an investment firm.

Show more...

Investment focus

  • Medical, Semiconductor, Clinical Trials
  • Seed
  • Belgium

Portfolio highlights

  • EDGX — EDGX, founded in 2023 in Ghent, is a Belgian Space Tech company developing high-speed edge computing units for satellites. Its NVIDIA-powered Sterna Computer and SpaceFeather software enable real-time, AI-driven on-orbit data processing for applications in communication, Earth observation, and intelligence.
  • Flindr Therapeutics — Immagene develops personalized cancer immunotherapies to fight multiple cancer type.
  • Clouds of care — Increasing your probability of success through the adoption of meaningful endpoints, starting from electrophysiology.
Show all investments...

Thuja Capital
VC Fund · Utrecht, Utrecht, The Netherlands · 1 investment in the past 12 months

Thuja Capital invests in early stage medical product innovations for diagnosis, cure, care or prevention.

Show more...

Investment focus

  • Biotechnology, Medical, Health Care
  • Funding Round, Series A, Seed
  • The Netherlands, Belgium, United States

Portfolio highlights

  • Pan Cancer — Pan Cancer T is an immunotherapy company developing next-generation TCR-T cell therapies for solid cancer.
  • Synerkine Pharma — Synerkine Pharma. Connecting Cytokines for the benefit of patients.
  • Artica Therapeutics — Artica Therapeutics specializes in biotechnological research and development for medical devices, pharmaceutical processes, and food.
Show all investments...

NV Industriebank LIOF
VC Fund · Maastricht, Limburg, The Netherlands

NV Industriebank LIOF is the Limburg development and investment company. LIOF contributes to the prosperity of the province with an ongoing program to strengthen the province's economic base. LIOF targets industry and the dynamic service sector.Its four core activities are Acquisition, Participation, Development/Innovation andBusiness Parks, as these relate to the location/relocation of (foreign) companies, venture capital participation in Limburg companies with prospects, the development/implementation of programs and projects to sharpen the competitive edge of Limburg business and the coordination of the development of new business parks.LIOF has a strategic approach which targets opportunities for long-term economic development. In this it has a bridging role between government and business. LIOF is an ambitious professional organization and speaks the language that business understands.

Show more...

Investment focus

  • Biotechnology, Medical, Health Care
  • Funding Round, Series A, Seed
  • The Netherlands, Belgium

Portfolio highlights

  • Ansana — Ansana develops sterilization solutions for the pharmaceutical and healthcare industries. This technology is significantly cutting patient risk, reducing the environmental imprint, lowering expenses, and increasing flow.
  • Mosa Meat — Mosa Meat produces slaughter-free hamburgers. The burger is harvested from cow cells, rather than raising and slaughtering a whole animal. By growing meat naturally from cells, Mosa Meat strives to accelerate the transition to a truly sustainable global food system.
  • SpecifAi Parking — Maximize your revenue, increase your efficiency and streamline your parking operation.
Show all investments...

SFPI-FPIM
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium

The Federal Holding and Investment Company (SFPI-FPIM) centrally manages the federal government’s shareholdings, cooperates with the government on specific projects and pursues its own investment policy in the interests of the Belgian economy.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical Device
  • Funding Round, Series B, Series A
  • Belgium, United States, France

Portfolio highlights

  • Cohabs — We create sustainable & community-driven shared homes around the world for young workers and interns. Join our community.
  • Univercells — We are biotech innovators, rooted in Belgium, driven by one purpose: To transform how biotech drugs are made so everyone, everywhere, can get them.
  • Tangent Works — Create predictive models in seconds for faster and better forecasting & anomaly detection with TIM InstantML.
Show all investments...

Investsud
VC Fund · Marche-en-famenne, Luxembourg, Belgium · 1 investment in the past 12 months

Investsud is a capital firm that works on investments in different industries including food, general industry, and technological startup.

Show more...

Investment focus

  • Biotechnology, Medical, SaaS
  • Series A, Seed, Series B
  • Belgium, France

Portfolio highlights

  • TrustUp — TrustUp is the home contractors platform, connects homeowners with verified quality home improvement.
  • Brenus Pharma — Unlocking the full potential of immuno-oncology by generating first-in-class immunotherapies to initiate a multi-specific in vivo immune response against tumors
  • AbolerIS Pharma — AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.
Show all investments...

Virginie Saverys
Angel

Virginie Saverys is a entrepreneur.

Show more...

Investment focus

  • Medical, Life Science, Biotechnology
  • Seed
  • Belgium

Portfolio highlights

  • 4Tissue — Shaping the Future of Regenerative Medicine
Show all investments...

Annemie Van de Casteele
Angel · 1 investment in the past 12 months

Annemie Van de Casteele is a former member of the Belgian Parliament.

Show more...

Investment focus

  • Medical, Life Science, Biotechnology
  • Seed
  • Belgium

Portfolio highlights

  • 4Tissue — Shaping the Future of Regenerative Medicine
Show all investments...

Ackermans & van Haaren
VC Fund · Antwerpen, Antwerpen, Belgium

Ackermans & van Haaren is a diversified group active in 5 segments: Marine Engineering & Infrastructure; Private Banking; Real Estate, Leisure & Senior Care; Energy & Resources; Development Capital. Marine Engineering & Infrastructure: DEME, one of the largest dredging companies in the world - Algemene Aannemingen Van Laere,a leading contractor in Belgium. Ackermans & van Haaren is an independent and diversified group aiming at creating shareholder value through long-term investments in a limited number of companies with growth potential on an international level.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • Belgium, India

Portfolio highlights

  • AstriVax — AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline.
  • Medikabazaar — Medikabazaar is an online B2B marketspace for medical supplies and equipment. They are a single point of contact for all product-based needs, enabling medical institutions and individual practitioners alike to cut down on operational costs and making the best global brands available locally, all aided with the miracle that goes by the name oftechnology. They are connected with more than 50,000 medical establishments, 1,50,000 Independent Practitioners, and have partnered with 13,000+ suppliers all over India including ones in Tier 2, Tier 3 cities, and remoter locations to establish a strong foothold in India and simultaneously earn the respect of our clients. With the power of technology, we organized a haywire market in a country with perhaps the largest and most complex geographical structure in the world for this purpose. Our last-mile delivery system and 26 strategically placed Fulfilment Centres across India enable us to deliver essential medical supplies to healthcare facilities and help them nurture quality and timely patient care. With our first international office in the Middle East, we are transcending boundaries to deliver care, everywhere.
  • Vico Therapeutics — Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly targeting the CAG repea
Show all investments...

Yves Berquin
Angel · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 1 investment in the past 12 months

Yves Berquin is the Co-Founder and Co-CEO of Matrix Requirements. He attended Free University of Brussels. .

Show more...

Investment focus

  • Medical, Health Care, Information Technology
  • Seed
  • Belgium

Portfolio highlights

  • Salvus Health — Salvus Health is het platform voor preventieve en farmaceutische diensten in de apotheek.
Show all investments...

Jurgen De Baerdemaeker
Angel · Herne, Vlaams-Brabant, Belgium · 1 investment in the past 12 months

Jurgen De Baerdemaeker

Show more...

Investment focus

  • Medical, Health Care, Information Technology
  • Seed
  • Belgium

Portfolio highlights

  • Salvus Health — Salvus Health is het platform voor preventieve en farmaceutische diensten in de apotheek.
Show all investments...

Limburg Startup
VC Fund · Maastricht, Limburg, The Netherlands

Limburg Ventures is a venture capital fund that invests in startups in life sciences and related fields of advanced chemicals and materials.

Show more...

Investment focus

  • Biotechnology, Life Science, Health Care
  • Funding Round, Series A, Series B
  • The Netherlands, France, Belgium

Portfolio highlights

  • FABPulous — FABPulous is an innovative healthcare company which develops and markets solutions for diagnostics in primary care and emergency medicine.FABPulous is a company based in The Netherlands. It was spun out of Maastricht University at the end of 2008. In December 2009 FABPulous closed a first equity financing round co-led by Thuja Capital, HealthInnovations, Limburg Ventures and NV Industriebank LIOF.The company has developed a technology that allows a simple, robust and ultra-rapid diluted plasma preparation from a drop of blood. This offers great advantages in the point-of-care (POC) and home testing setting, over current technology. It concerns a disposable plasma preparation device that can be integrated with many IVD detection platforms, such lateral flow devices. The first product application under development by FABPulous is a rapid test for the cardiac biomarker heart-type fatty acid binding protein (H-FABP), to aid in the first-line diagnosis of acute myocardial infarction.
  • Kriya Materials — Kriya Materials is the innovative developer and manufacturer of various metal oxide nano particles as well as their downstream dispersions and functional coating products thereof. Coatings play an important role in our everyday life, although often not recognized by those who do not master the art. Coatings are a big market and many products fallunder this category. Kriya Materials focuses itself on the development and manufacturing of various nano metal oxides which it uses internally for the development and production of very high end coatings.The coatings made by Kriya Materials are applied in a wide range of markets, some examples are the Plasma Panel and LCD industry, from Smartphone to touch panels to glass surfaces.
  • ReSolved Technologies — ReSolved Technologies are dedicated to increase the circularity of engineering plastics by addressing complex waste streams. They do this by extracting valuable plastics from these difficult-to-recycle waste streams and convert them to recycled material of near-virgin quality that is suited for closed-loop recycling in high-end markets.
Show all investments...

Hunza Ventures
VC Fund · Luxembourg, Luxembourg, Luxembourg

Hunza Ventures is a venture capital firm incorporated in 1998 in Luxemburg. The firm has focused its investments on early and mid-stage life sciences and IT companies with outstanding growth prospects.Hunza Ventures has built a large and well-balanced portfolio based on the strong entrepreneurial experience of the fund’s shareholders andmanagers. Since inception, Hunza Ventures has backed 20 companies in Belgium, Israel, USA and Singapore.Hunza Ventures has raised two funds:Hunza Ventures raised €15 million. The fund made 14 venture investments and is fully invested. A series of companies have successfully been divested.Hunza Ventures II raised €6.25 million in October 2008. This fund is actively investing and is currently raising additional capital.

Show more...

Investment focus

  • Medical, Health Care, Biotechnology
  • Series A, Funding Round
  • Belgium, United States

Portfolio highlights

  • ITeos Therapeutics — iTeos Therapeutics is pioneering the discovery and development of highly differentiated immuno-oncology therapeutics for cancer patients.
  • Formac Pharmaceuticals — Formac is a spin-off company from the University of Leuven, Belgium (K.U.Leuven), from which it has obtained the exclusive and worldwide rights to develop and commercialise ordered mesoporous silica materials for the delivery of poorly soluble API's. The company was incorporated on 3 October 2007 and is privately owned. The main shareholdersof Formac are K.U.Leuven, Allegro Investment Fund, Hunza Ventures, Gemma Frisius Fonds K.U.Leuven, Vinnof PMV and Life Sciences Research Partners VZW (formerly D. Collen Foundation).Since its incorporation Formac has signed more than 40 feasibility agreements with Tier 1 Pharma companies and SMEs in the field of human and veterinary medicine. To date, Formac is the only company that demonstrated the clinical relevancy of the silica based technology in a clinical setting.
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 19 investments in the past 12 months

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • France, United States, United Kingdom

Portfolio highlights

  • Moon Surgical — MastOR is a medical device company developing a surgical robot for laparoscopy assistance. MastOR is an early-stage surgical robotics company whose laparoscopy assistance platform broadens access to minimally-invasive techniques for surgeons and optimizes resource utilization in the operating room.
  • BrightHeart — BrightHeart develops an AI-based platform for fetal ultrasound analysis to improve detection of congenital heart defects.
  • Alia Therapeutics — Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.
Show all investments...

Yonjin Venture
VC Fund · Cambridge, Massachusetts, United States · 2 investments in the past 12 months

Yonjin Venture is an investment firm specializing in investing in early and mid-stage life science companies.It focuses on the innovative technologies in therapeutics, diagnostics, and medical devices. The firm is a sub-organization of Yongjin Group and the sister firm of Yonghua Capital.The Cambridge, Massachusetts-based firm was establishedin 2018.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • United States, China, Israel

Portfolio highlights

  • CSA Medical — RejuvenAir System aims to treat Chronic Bronchitis. The SPRAY-CB trial is evaluating the safety of the device and is currently recruiting in the USA.
  • HistoSonics — HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels.
  • EvolveImmune Therapeutics — EvolveImmune Therapeutics transforms the discovery and development of novel immunotherapies. By leveraging its proprietary in vivo target discovery platform, EvolveImmune is building a pipeline of novel therapeutic candidates against numerous targets that are expressed on multiple immune cell types. The company’s platform will generatefirst-in-class treatments for unmet needs in oncology and autoimmune diseases.
Show all investments...

The CoFoundry
VC Fund · Antwerp, Antwerpen, Belgium

The CoFoundry helps entrepreneurs transform their ideas into sustainable companies. Some say we cut through the funding hype and work hard to give your business a sustainable future.

Show more...

Investment focus

  • Software, Network Security, SaaS
  • Seed, Series A, Funding Round
  • Belgium, The Netherlands, United States

Portfolio highlights

  • Aloxy — Aloxy offers reliable IIot solutions tailored to the needs of the process industry. Our valve sensor provides an open and close indication of manual valves.
  • MyCellHub — MyCellHub.com is a pre-startup from the KULeuven in the biotherapeutics industry that aspires to reform the way cell production processes are organised. With a regulatory compliant Saas-platform for data management and analytics, we increase the efficiency of your manufacturing processes, provide actionable insights via cell culture specificprocess analytics and facilitate regulatory compliance by means of a real-time audit trail and automated batch records.
  • Vaultspeed — Save your teams months of headache with a no-code approach to automate your multi-source data integration, Data Vault modeling & ETL/DDL code generation.
Show all investments...

Gimv
VC Fund · Antwerpen, Antwerpen, Belgium · 4 investments in the past 12 months

Gimv, a trusted European investment company, helps mid-market businesses create sustainable value through growth capital and expertise across diverse sectors.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series B, Funding Round, Private Equity
  • Belgium, United States, France

Portfolio highlights

  • Curana — Curana is a manufacturer of bike equipment and accessories.
  • Kivu Bioscience — At Kivu Bioscience, we leverage advanced, next-generation proprietary ADC technologies to deliver more precise and effective cancer treatments.
  • ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Show all investments...

Delta Partners
VC Fund · Leopardstown, Dublin, Ireland

Early stage VC investments and funding for start-ups / founders in Ireland.

Show more...

Investment focus

  • Software, Information Technology, Health Care
  • Funding Round, Seed, Series A
  • Ireland, United States, United Kingdom

Portfolio highlights

  • Imvizar — Transform your buildings, office spaces, visitor attractions, and parks with an immersive and visual storytelling experience using augmented reality. Discover unique ways to tell your story at Imvizar.
  • ZeroMission — ZeroMission is an electromobility and lead innovator in software development, and power-energy infrastructure.ZeroMission offers fleet management software to businesses that own and operate fleets of commercial electric vehicles (EVs).
  • MarketSizer — MarketSizer offers subscription-based competitive intelligence and market insights for SaaS vendors who want to strategically grow their business.
Show all investments...

TCD Capital (ex TheClubDeal)
VC Fund · Uccle, Brussels Hoofdstedelijk Gewest, Belgium · 2 investments in the past 12 months

TheClubDeal is an investment holding and fund manager co-investing into SME’s and real estate projects. It provides facilitation of governance between non-executive shareholders and entrepreneurs. Its governance structure, including its charter of avoidance of conflict of interests, is therefore paramount to the adequate management of the Company.At TheClubDeal, we connect Investors and Entrepreneurs around promising investment opportunities. For each of these, we will invest ourselves and co-invest with a selected number of investors. We add value by processing strong applied governance principles, when selecting and managing our investments, and by gathering the necessary skills to successfully grow the businesses and real-estate projects we co-invest in. TheClubDeal is launching their second fund, a 50M € PRIVAK/PRICAF in H1 2021 with the mandate to invest in Belgian scale-ups in three sectors: Smart Living, Tech and Life Sciences.

Show more...

Investment focus

  • Health Care, Biotechnology, Information Technology
  • Series A, Series B, Seed
  • Belgium, France

Portfolio highlights

  • Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.
  • Inpulse — Inpulse is an automated supply management platform for restaurateurs.
  • Clouds of care — Increasing your probability of success through the adoption of meaningful endpoints, starting from electrophysiology.
Show all investments...

Jean Dessain
Angel · Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Jean Dessain - Non Executive Director @ OneLIFE

Show more...

Investment focus

  • Medical, Health Care, Biotechnology
  • Angel
  • Belgium

Portfolio highlights

  • OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.
Show all investments...

Fountain Healthcare Partners
VC Fund · Dublin, Dublin, Ireland · 1 investment in the past 12 months

Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical
  • Series A, Series B, Series C
  • Ireland, United States, France

Portfolio highlights

  • Mainstay Medical — Mainstay Medical is improving quality of life for patients with chronic low back pain through innovative restorative treatment medical device solutions.
  • Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
  • XyloCor Therapeutics — XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease. The company's service focuses on developing gene therapy to stimulate the formation of new coronary blood vessels and serve areas of the heart that are not receiving adequate blood supply, enabling patientswith refractory angina who exhausted pharmacologic options to cure their cardiovascular diseases painlessly and cost effectively.
Show all investments...

Yves Beudin
Angel · Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Yves Beudin

Show more...

Investment focus

  • Medical, Health Care, Biotechnology
  • Angel
  • Belgium

Portfolio highlights

  • OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.
Show all investments...

georges verpraet
Angel · 1 investment in the past 12 months

georges verpraet

Show more...

Investment focus

  • Medical, Health Care, Information Technology
  • Seed
  • Belgium

Portfolio highlights

  • Salvus Health — Salvus Health is het platform voor preventieve en farmaceutische diensten in de apotheek.
Show all investments...

Allegro Investment Fund
VC Fund · Heverlee, Vlaams-Brabant, Belgium

Allegro Investment Fund is an open end seed capital investment fund, focussing on high-tech ventures. With a combined experience of more then 40 years of experience in high-tech start-up management, the AIF team adds smart money to your capital needs.

Show more...

Investment focus

  • Software, Hardware, Apps
  • Funding Round, Series A, Series B
  • Belgium, United States, The Netherlands

Portfolio highlights

  • Visys — Visys NV, The optical sorting innovation Company, is a leading state-of-the-art provider of Digital automated sorting solutions to the global food and non-food processing industry.
  • Mass Relevance — Mass Relevance develops and offers cloud-based software for media and entertainment sectors.Its software enables social media content aggregation, filtration, and integration. The company's clientele includes December, 2010. The company was founded in 2009 and is based in Austin, Texas.In April 2014, Mass Relevance merged with Spredfast, forming a comprehensive social marketing company.
  • GreenPeak Technologies — GreenPeak Technologies operates as a fabless semiconductor and is one of the leaders in the ZigBee market with a rich offering of RF chips for the Smart Home and the IoT.Driven by the world’s MSOs, GreenPeak is proving its market leadership position as the Internet of Things connectivity technology provider for the Smart Home.GreenPeakTechnologies is a fabless semiconductor company and the leader in the ZigBee market with a rich offering of semiconductor products and software technologies for Smart Home data communications and the Internet of Things.The GreenPeak founders have significantly contributed to the invention of WiFi and made it into a commercial success, used by several billion people today. GreenPeak is recognised as a leader in developing new wireless technologies for consumer electronics, Smart Home applications and the IoT/IoE, demonstrating rapid growth and adoption by major customers around the globe.It offers its products for original equipment manufacturers in the United States, Europe, and Asia. The company was formerly known as Xanadu Wireless and changed its name to GreenPeak Technologies B.V. in 2007. GreenPeak Technologies was founded in 2004 and is based in Utrecht, the Netherlands with additional offices in Belgium, Japan, France, California, US as well as in Korea and Hong Kong.
Show all investments...

Evren Ucok
Angel · Istanbul, Istanbul, Turkey

Evren Ucok is a co-founder and investor at Peak Games, an interactive social game development platform. He is also a partner at Earlybird Venture Capital, an investment fund-based in Europe that focuses on emerging companies; Trendyol.com, a fashion e-commerce site; and Oliver Wyman.

Show more...

Investment focus

  • Medical, Health Care, Life Science
  • Series A
  • Turkey, Belgium

Portfolio highlights

  • idemama — Idemama is an online platform that provides its users with web and graphic design services. It is based in Istanbul, Turkey.
  • Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Show all investments...
Investors by industry
Investors by country
Investors in Belgium by industry

Contact investors today

Find who invests in your industry, stage, and country in 5 minutes.

Find investors — It's Free!